P/B
4,9
Thermo Fisher Scientific
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
$265.9B
Market Cap • 11/11/2026
1956
(70 years)
Founded
1972
(54 years ago)
IPO
NYSE
Listing Exchange
United States
Country
S&P500 Participant
Index Composite • 2026
Valuation
P/S
5,6
P/EBITDA
23
P/OCF
28,5
P/FCF
35
P/E
37,9
BVPS
147,8
EPS
19
Market Cap
Market Cap
265,9B
EV
301,4B
EV/Revenue
6,4
EV/EBITDA
26
EV/EBIT
35,6
Payout
Dividend Per Share
1,8
Dividend Yield
0,3%
Buyback Yield
1,5%
Total Yield
1,8%
Dividend Yield 5Y
0,3%
Payout
9,5%
Retained Earnings
63,7B
Profitability
Gross Margin
41,1%
EBITDA Margin
24,4%
EBIT Margin
17,9%
Net Margin
15%
D&A/EBITDA
12,4%
R&D/Revenue
3%
Capex/Revenue
3,6%
Capex/D&A
55,6%
Capex/OCF
18,5%
SBC/OCF
3,7%
% PPE
9,3%
% Goodwill
47,5%
ROE
13,4%
ROIC
8,3%
Growth
CAGR Revenue 5Y
3,9%
CAGR Op. Income 5Y
-4,3%
CAGR Net Income 5Y
-3,7%
CAGR EPS 5Y
-2,5%
CAGR OCF 5Y
-1,8%
Leverage
N.D./EBITDA
3,1
Debt/Equity
0%
Current Ratio
1,8
Quick Ratio
1,1
Interest Coverage
550,9%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!